🔎 Trials Near Me

Gara Jalqabaatti › Saree Oljoo › Delaware › Newark

Qorannoo klinikaalii Saree Oljoo Newark, DE keessatti

Qorannoo 8 Saree Oljoo f Newark fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Medical Oncology Hematology Consultants, Newark
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Namoota walitti qabaa jiraSadarkaa 3
  • Medical Oncology Hematology Consultants (MOHC) ( Site 8002), Newark
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07060807

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Medical Oncology Hematology Consultants, P.A., Newark
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06982521

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Namoota walitti qabaa jiraSadarkaa 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
  • fi 1 dabalataa
Umuriin 18 hanga 60 · Dubartoota · Haaromfame 02-Ful-2026 · NCT05879926

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Namoota walitti qabaa jiraSadarkaa 2/3
  • Medical Oncology Hematology Consultants, PA, Newark
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06926868

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care - Union Hospital, Elkton · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Newark
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Medical Oncology and Hematology Consultants, Newark
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2025 · NCT03053193

Qorannoo Saree Oljoo magaalota biroo keessatti

Qorannoo biroo Newark keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.